Covid-19: See latest data on suppliers and inventory

LUMINEX logo

LUMINEX

PSF Verified
12212 Technology Blvd, Suite 130, Austin, TX 78727, United States
Luminex Corporation specifies their major offering areas as: Clinical Diagnostics and Research Diagnostics. Clinical Diagnostics include: Infectious Disease Diagnostics, IVD-Cleared Genetic Tests, Diagnostic Reagents, Clinical Research, Clinical Instruments, and Clinical Technology. Research Diagnostics include: Reagents & Accessories, Multiplexing Technologies, xMAP Instruments, and Flow Cytometry & Imaging.
DUNS #:
965476641
CAGE Code:
1K8M4
Type:
Services Provider
Employees:
500-1,000
Annual Revenue:
$100M-$500M
Year Founded:
1995
Country of Origin:
United States
Sectors Served:
US Federal, US State, US Local, Private Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

COVID‑19 Testing, Health Diagnostics, Coronavirus (COVID-19) Diagnostics, Respiratory Infection Diagnostics, Bloodstream Infection Diagnostics, Gastrointestinal Infection Diagnostics, Healthcare-as...

COVID-19 Supplies1

Are you making PPE or ventilators for COVID-19?
Let us know
Categories
Products Available
Inventory/Capacity
Certification
Available Contracts
Contact Info
COVID-19 Testing
ARIES SARS-CoV-2 Assay - Molecular Test
Available
no data
no data

Contact Info5

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Certifications1

Certificate Name
Expiration Date
Certifying Organization
Attachment
FDA

FDA

FDA

Certificate Name

FDA

Expiration Date

Certifying Organization

FDA

Attachment

PRODUCTS AND SERVICES2

ARIES SARS-CoV-2 Assay
1 past experience
ARIES SARS-CoV-2 Assay is a sample-to-answer test that detects the SARS-CoV-2 virus. It is authorized by the FDA under Emergency Use Authorization.
xMAP SARS-CoV-2 Multi-Antigen IgG Assay
Luminex Corporation offers xMAP SARS-CoV-2 Multi-Antigen IgG Assay that detects IgG antibodies in human serum and dipotassium EDTA plasma using Luminex 200, MAGPIX, MAGPIX NxTAG enabled, and FLEXMAP 3D Systems. It is authorized by the FDA under EUA.

Past experience4

other
SARS-CoV-2 Assay
Luminex won BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test. Luminex received $642,450 to support development...
SBIR
Development of a field deployable cell anal...
DESCRIPTION (provided by applicant): The proposed technology aims at creating a simple, low-cost and rugged cell analyzer capable of...
SBIR
take a walkSBIR Phase I: Portable and Autom...
This Small Business Innovation Research (SBIR) Phase I project builds the foundation for a fully automated and portable multiplex di...
SBIR
Universal Sample Preparation Device for Bio...
Reliable sample preparation from a variety of complex matrices remains one of the most challenging problems facing biological detect...

Existing Contracts1

Contract Vehicle Type
Contract Name
Contract #
Who Can Use
Managing Organization
Exp. Date
Federal Schedules
GSA Schedules
47QSWA20D0021
Federal
​U.S. General Services Administration (GSA)
Dec 02, 2024

Locations served1

  • United States 7 locations
My Notes
Contact
My Notes